Page 78 - புனே அடிப்படையிலானது சீரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AstraZeneca sends legal notice to SII over delays in vaccine supply | India News

MUMBAI: The UK-headquartered drug firm AstraZeneca has served a legal notice to its manufacturing partner, Pune-based Serum Institute of India, over delays in the supply of its Covid-19 vaccine. The notice comes after Serum Institute delayed shipment of vaccines to the UK, and later did not meet its obligations to other countries that are part of the Covax programme. Serum Institute has attributed the delay to the Centre’s decision to halt vaccine exports, while its CEO, Adar Poonawalla, according to media reports, said SII would prioritise domestic needs temporarily. In mid-March, the Centre decided to go slow on vaccine exports amidst a huge surge in Covid-19 cases. Demand for vaccines has also jumped after the government broadened its immunisation drive, relaxing the eligibility criteria for the 45-years-plus age group from April 1.

United kingdomAdar poonawallaSerum instituteSerum institute of indiaUnited kingdom headquarteredPune based serum instituteBharat biotechஒன்றுபட்டது கிஂக்டம்அடார் பூனாவல்லசீரம் நிறுவனம்சீரம் நிறுவனம் ஆஃப் இந்தியாபுனே அடிப்படையிலானது சீரம் நிறுவனம்பாரத் பயோடெக்

Now AstraZeneca Sends Legal Notice To Serum Institute Over Vaccine Delays: Here s What Happened

Now AstraZeneca Sends Legal Notice To Serum Institute Over Vaccine Delays: Here s What Happened Indiatimes 4 hours ago © Provided by Indiatimes British-Swedish pharmaceutical giant AstraZeneca which has been going through a rough patch over its COVID-19 vaccine s safety concerns and anger in the EU over failing to fulfil its promise has sent a legal notice to Pune-based Serum Institute of India (SII) over its delay in shipments. The SII, which is the world s largest vaccine maker had entered into a deal with AstraZeneca to manufacture its COVID-19 vaccine in India under the brand name Covishield. © Provided by Indiatimes AFP What happened?

United kingdomCote divoireAdar poonawallaEu commissionSerum institute of indiaPune based serum instituteSerum instituteCoted ivoirePresident vonஒன்றுபட்டது கிஂக்டம்அடார் பூனாவல்லயூ தரகுசீரம் நிறுவனம் ஆஃப் இந்தியாபுனே அடிப்படையிலானது சீரம் நிறுவனம்சீரம் நிறுவனம்ப்ரெஸிடெஂட் வான்

health and nutrition: Union Minister Harsh Vardhan launches tribal health collaborative Anamaya , Health News, ET HealthWorld

health and nutrition: Union Minister Harsh Vardhan launches tribal health collaborative Anamaya , Health News, ET HealthWorld
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Serum institute of indiaUnited kingdom headquarteredPune based serum instituteசீரம் நிறுவனம் ஆஃப் இந்தியாபுனே அடிப்படையிலானது சீரம் நிறுவனம்

Migrant Workers Return Home Again; Notice To SII Over Vaccine Delays + More Top News

Migrant Workers Return Home Again; Notice To SII Over Vaccine Delays + More Top News
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

New zealandUnited kingdomSonika shirivastvaJacinda ardernSerum institute of indiaPune based serum instituteRoorkee test positive forDoctors getting infected withAfter both vaccines is worrisomeNone evenபுதியது ஜீலாந்துஒன்றுபட்டது கிஂக்டம்சீரம் நிறுவனம் ஆஃப் இந்தியாபுனே அடிப்படையிலானது சீரம் நிறுவனம்

WHO rejects serum institute proposal extension covishield shelf life 9 months

URL copied Image Source : FILE/PTI WHO rejects Serum Institute s proposal seeking extension of Covishield s shelf life from 6 to 9 months The WHO has rejected Serum Institute of India s proposal seeking extension of the shelf life of Oxford-AstraZeneca COVID-19 vaccine, Covishield, from six to nine months, citing insufficient data, sources said. The WHO has also sought a meeting with Drugs Controller General of India (DCGI) to discuss the matter, they said. The move comes even as India s drug regulator has extended Covishield s shelf life from six to nine months from its manufacturing date. In a recent communique to Pune-based Serum Institute of India (SII), the WHO has also asked the firm to formulate the doses with enough titer and/or implement a higher specification at release so that the minimum specification ofÂ â¥Â 2.5 x 108 ifu/dose is fulfilled throughout the shelf life.

United kingdomHimachal pradeshEuropean unionSerum instituteCentral drugs laboratoryOxford universitySerum institute of indiaImage sourceDrugs controller generalPune based serum instituteஒன்றுபட்டது கிஂக்டம்கச ul லிஇமாச்சல் பிரதேஷ்ஐரோப்பிய தொழிற்சங்கம்சீரம் நிறுவனம்மைய மருந்துகள் ஆய்வகம்